Jefferson scientists detail key molecular pathway and potential drug targets against cancer, Alzheimer's and Parkinson's diseases
Researchers have described how two similar proteins compete for control of a cell's ability to die at a preset time. Understanding the molecular secrets of apoptosis, or programmed cell suicide, they say, will enable scientists to identify potential drug targets against neurodegenerative and autoimmune diseases, and cancer.
NIH/National Institute of Aging
Steve Benowitz email@example.com
Thomas Jefferson University
Message posted by: Wouter Kalle